Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Spondylarthritis × Adalimumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Arthritis, Rheumatoid 9 Spondylitis, Ankylosing 2 Spondylarthritis 1 Psoriasis 1 Joint Diseases 1 Inflammatory Bowel Diseases 1 Crohn Disease 1 Colitis, Ulcerative 1 Autoimmune Diseases 1 Arthritis 1

Interventions

Tumor Necrosis Factor Inhibitors 1 Adalimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02492217 2020-11-03

Biomarkers Identification of Anti-tumor Necrosis Factor (TNF) α Agent's Efficacy in Ankylosing Spondylitis Patients

Universidade Nova de Lisboa

Phase 4 Completed

Spondylitis, Ankylosing, Spondylarthritis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡